Objectives: Previous research has reported a negative impact of olfactory dysfunction on quality of life (QoL) and depressive symptoms. As self-esteem was identified as a contributing factor to depression, this study aimed to investigate QoL, depressive symptoms and self-esteem in patients with smell loss.
| INTRODUCTION
Olfactory dysfunction is a common disorder, affecting about 12% of general population, increasing with higher age. 1 Interestingly, selfreports are hardly reliable with respect to objectively measured olfactory function. 2 Thus, smell disorders were often detected months after the actual onset. The effects of smell loss can be diverse. Affected patients are faced with a decreased ability to identify personal hazards, such as fire, gas or spoiled food. 3 Furthermore, previous research
suggests an impaired quality of life (QoL) and an increase in the risk of developing mental disorders (for review, see 4 ). The wide-spread consequences of smell loss do not only affect the patients themselves, they also cause a burden for the public and private health system.
Recent research observed effects of smell loss on everyday life even beyond obvious limitations with respect to personal hazards.
Many affected patients suffer from reduced QoL, and they have a higher risk to develop depressive symptoms. 5 Smeets et al. 5 found that olfactory dysfunctions had substantial effects on QoL, especially related to situations in which the chemical senses play an important role. Therefore, the authors suggest that cognitive behavioural interventions may be provided as support for patients with severe smell loss. A study published by Shu et al. 6 observed that olfactory loss was most challenging for younger patients with more severe olfactory disorders. Older patients, especially with longer disease duration, developed better coping strategies to reduce the influence of olfactory dysfunction on QoL. Previous research in the field of
depression identified lower self-esteem as a risk factor for developing depressive symptoms (for review, see 7 ) . Even though it has been shown that QoL was reduced in patients with olfactory dysfunction, little is known about the interplay of QoL, depressive symptoms and self-esteem. However, these parameters are of particular interest, to satisfy the patient's needs and provide the most promising therapeutic intervention.
It has been established that olfactory dysfunction and depressive symptoms are associated in two ways. First, patients diagnosed with major depressive disorder often exhibit decreased olfactory function (for review see 8 )
. Second, patients with olfactory loss are more likely to develop depressive symptoms. 9 Current estimates suggest that approximately one-third of patients with smell disorders show at least mild depressive symptoms. 4 A recent cohort-controlled study in patients with chronic rhinosinusitis assumed that depressive symptoms were underdiagnosed in this patient group. The authors detected depressive symptoms, using the Beck Depression Inventory (BDI), in nearly one-third of investigated patients.
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Although previous demographic investigations identified a correlation between smell disorders, a decrease in QoL, and a higher likelihood of developing depressive symptoms, little is known about the involvement of self-esteem in these factors in patients with smell disorders. Motivation and committment to therapy is often a crucial factor for successful treatment. Particularly in long-term interventions, such as olfactory training (for review, see 11, 12 ), it is extremely important to maintain compliance. We, therefore, aimed to investigate self-esteem, QoL and depressive symptoms in anosmic patients compared to healthy controls. Based on previous findings, we hypothesised a decreased self-esteem in anosmic patients compared to healthy controls.
| MATERIALS AND METHODS

| Ethical considerations
The study was performed in accordance with the Declaration of Helsinki (1964), and the study protocol was approved by the Ethics
Committee of the Medical University of Vienna. All subjects were informed about the aim of the study and gave written, informed consent prior to inclusion. Scores are presented as percentile ranks compared to a normative sample; for the MSWS, data from 17 anosmic patients and 12 healthy controls were available.
| Subjects
Keypoints
• Self-esteem is an important factor in anosmic patients.
• Self-esteem, quality of life and depressive systems act as highly interactive factors in anosmic patients.
• Self-esteem should therefore be assessed in medical history.
• Self-esteem may be important to provide a treatment adapted to the patient's needs.
| Behavioural data
Quality of life depicts the general well-being of a subject. Subjective QoL was assessed using the German version of the WHOQOL-BREF, 17 a self-reporting assessment. The WHOQOL-BREF is a short version of the WHOQOL-100, comprising 26 items, and covering four domains of QoL: physical health, psychological, social relationships and environment. The main advantage of this questionnaire is the quick and easy conduction. Furthermore, not only a general QoL will be assessed, but also information on different aspects will be provided in detail. Raw scores for each domain were transformed into percentile ranks according to normative data, as provided in Hawthorne et al. 18 Depressive symptoms were evaluated using the German version 
| Statistical analysis
Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS, Chicago, IL, USA), version 20.0. For all test scores, mean and standard deviation were calculated. As all variables fulfilled the requirements for parametric testing, data were analysed using a one-way multivariate analysis of variance (MANOVA). For group comparison of depressive symptoms, a two-sample t-test was performed. The alpha level for statistical testing was set to a=0.05.
In addition to traditional statistical parameters, the Bayes factor (BF) 21 will be reported for all univariate comparisons as well as for all correlations. The BF was calculated using the software JASP Figure 1 ). Detailed analysis, corrected for multiple testing using Bonferroni correction, revealed that olfactory dysfunction had a statistically significant effect on only one of the three subscales of the MSWS:
| Depressive symptoms
body-related self-esteem (F(1,27)=4.391, P=.046, x p ²=0.110), with decreased scores for patients with olfactory dysfunction (see Figure 1 ).
| DISCUSSION
| Synopsis and key findings
The main aim of the study was to investigate self-esteem and QoL in anosmic patients compared to healthy controls. The results of this study revealed that anosmic patients experience a decreased QoL in the psychological domain, and significantly reduced body-related self-esteem. The medium effect size (x p ²=0.110) suggests that the reduced body-related self-esteem is not only statistically significant, but also clinically relevant. Although no statistically significant differences in depressive symptoms were observed between anosmic patients and healthy controls, the scores in the psychological domain were highly correlated with depressive symptoms.
| Comparison with other studies
Low self-esteem has been considered an important factor in major depression disorder for decades. 22 Recent research discovered that low self-esteem is an important risk factor for the development of depressive symptoms across the complete life span. 7 This interaction was also found in patients with olfactory dysfunction who participated in the present study. Although no causal relationship can be derived from correlational analyses, the findings of our study are in line with the vulnerability model of depression (for review, see 23 ), which assumes that low self-esteem is a risk factor for depression.
Self-esteem has already been identified as an important factor in self-reported QoL. 24 A recent study in breast cancer survivors reported self-esteem as the strongest predictor of global QoL. 25 It is assumed that higher self-esteem has a positive effect on coping strategies, 26 and on managing the stress in chronic or life-threatening diseases. 27 The results of the present study have shown that self-esteem is highly associated with QoL, and with depressive symptoms in anosmic patients. Furthermore, a recent study in patients with cardiovascular conditions reported a significant association between low self-esteem and non-compliance. 28 The results of the present study have
shown that QoL, self-esteem, and depressive symptoms are highly interactive in patients with olfactory dysfunction. Therefore, these variables should be taken into account in patients with smell disorder, in order to provide a personalised intervention approach adapted to the individual needs of the patient. Future large-scale, cohort-controlled studies may discover the importance of treating any accompanying depressive symptoms and low self-esteem along with therapy for an olfactory disorder, to strengthen the effect of the olfactory training.
| Strengths and limitations of the study
This is the first study investigating the impact of self-esteem on QoL and depressive symptoms in anosmic patients. Data of a F I G U R E 1 Mean percentile ranks of (A) WHOQOL-BREF and (B) MSWS in patients with anosmia and healthy controls. Significant differences are marked with an asterisk homogeneous study sample of anosmic patients were acquired.
However, there are still some limitations on this study. A potential limitation of this study is that healthy controls were significantly younger than patients with olfactory dysfunction. However, no significant correlations between age and the behavioural measures 
| CONCLUSION
The present study is the first investigating self-esteem in patients with anosmia. The results have shown that self-esteem plays a crucial role in these patients. We assume that self-esteem and QoL are important factors in the risk for developing depressive symptoms in patients with smell disorder. We therefore suggest collecting data Sch€ opf wrote the manuscript. All authors revised the article critically.
